Health
Sequencing Study from Roswell Park Highlights Previously Unknown Myeloma Resistance Mechanisms – Newswise
— A group of researchers led by Maximillian Merz, MD, Assistant Professor of Oncology with the Myeloma team at Roswell Park Comprehensive Cancer Center, condu
- First single-cell analysis in a prospective trial for patients with myeloma
- Plasma-cell clones responsible for characteristic bone lesions, team shows
- Findings suggest new strategies for eradicating minimal residual disease
Newswise — BUFFALO, N.Y. — A group of researchers led by Maximillian Merz, MD, Assistant Professor of Oncology with the Myeloma team at Roswell Park Comprehensive Cancer Center, conducted the first prospective clinical trial investigating spatial heterogeneity in patients with either…
Continue Reading
-
General24 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General16 hours agoAustralia’s Diamonds defeat South Africa’s Proteas 65-42 in third netball Test
-
Noosa News21 hours agoSerious traffic crash, Noosa – Sunshine Coast
-
General17 hours agoThousands join pro-Palestinian rallies in towns and cities across Australia amid ceasefire